Compound derived from 2-benzothiazolone, beta2 adrenergic agonist； Crystal form； Preparation Process； Pharmaceutical composition that comprises； Pharmaceutical Combination； method to Treat or prevent disuse atrophy associated with muscular dystrophy, or cachexia, sarcopenia.

• 收藏
• 分享

专利权人:

NOVARTIS AG

发明人:

GRANDEURY ARNAUD,TUFILLI NICOLA

申请号：

CL2015000461

公开号：

CL2015000461A1

申请日:

2015.02.25

申请国别(地区):

CL

年份:

2015

代理人:

摘要：

The present invention provides a compound of formula (I) in glycolate salt form a method for manufacturing the compound of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and pharmaceutical compositions.FORMA CRISTALINA DE ACETATO DE (R)-7-(2-(1-(4-BUTOXI FENIL)-2-METIL PROPAN-2-IL AMINO)-1-HIDROXI ETIL)-5-HIDROXI BENZO [d] TIAZOL-2(3H)-ONA； COMPOSICIÓN Y COMBINACIÓN FARMACÉUTICAS； Y SU USO PARA TRATAR O PREVENIR DISTROFIA MUSCULAR, ATROFIA RELACIONADA CON DESUSO, CAQUEXIA O SARCOPENIA.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/